Dopamine pathology in schizophrenia: Analysis of total and phosphorylated tyrosine hydroxylase in the substantia nigra

Frontiers in Psychiatry

Volumn 3, Issue APR, 2012, Pages

  Perez Costas, Emma ^a   Melendez Ferro, Miguel ^a   Rice, Matthew W ^a   Conley, Robert R ^b   Roberts, Rosalinda C ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Human brain; Neuropsychiatric disorders; Postmortem studies; Rat brain; Western blot

Indexed keywords

ACTIN; DOPAMINE; HALOPERIDOL; MESSENGER RNA; OLANZAPINE; TYROSINE 3 MONOOXYGENASE;

ADULT; AGE DISTRIBUTION; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CADAVER; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MALE; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PH; PILOT STUDY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RACE DIFFERENCE; RAT; SCHIZOPHRENIA; SUBSTANTIA NIGRA; TYROSINE HYDROXYLASE GENE; VENTRAL TEGMENTUM;

EID: 84866879365     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2012.00031     Document Type: Article

References (55)

1. Abi-Dargham, A., Slifstein, M., Kege-les, L., and Laruelle, M. (2010). "Dopamine dysfuction in schizophrenia," in Dopamine Handbook, eds L. L. Iversen, S. D. Iversen, S. B. Dunnett, and A. Bjorklund (Oxford: Oxford University Press), 511-519.
2. Akil, M., Edgar, C. L., Pierri, J. N., Casali, S., and Lewis, D. A. (2000). Decreased density of tyrosine hydroxylase-immunoreactive axons in the entorhinal cortex of schizophrenic subjects. Biol. Psychiatry 47, 361-370.
3. Akil, M., Pierri, J. N., Whitehead, R. E., Edgar, C. L., Mohila, C., Sampson, A. R., and Lewis, D. A. (1999). Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am. J. Psychiatry 156, 1580-1589.
4. Alterio, J., Mallet, J., and Biguet, N. F. (2001). Multiple complexes involved in tyrosine hydroxylase mRNA stability in rat adrenal medulla, after reserpine stimulation. Mol. Cell. Neurosci. 17, 179-189.
5. Andreou, D., Saetre, P., Lundmark, P., Hansen, T., Timm, S., Melle, I., Djurovic, S., Andreassen, O. A., Werge, T., Hall, H., Agartz, I., Terenius, L., and Jonsson, E. G. (2009). Tyrosine hydroxylase Val81Met polymorphism: lack of association with schizophrenia. Psy-chiatr. Genet. 19,273-274.
6. Burgert, E., Crocq, M. A., Bausch, E., Macher, J. P., and Morris-Rosendahl, D. J. (1998). No association between the tyrosine hydroxylase microsatellite marker HUMTH01 and schizophrenia or bipolar I disorder. Psychiatr. Genet. 8, 45-48.
7. Chao, H. M., and Richardson, M. A. (2002). Aromatic amino acid hydroxylase genes and schizophrenia. Am. J. Med. Genet. 114, 626-630.
8. Chen, X., Xu, L., Radcliffe, P., Sun, B., andTank,A.W. (2008).Activation of tyrosine hydroxylase mRNA translation by cAMP in midbrain dopamin-ergic neurons. Mol. Pharmacol. 73, 1816-1828.
9. Fallon, J. H., Koziell, D. A., and Moore, R.Y. (1978a). Catecholamine innervation of the basal forebrain II: amygdala, suprarhinal cortex and entorhinal cortex. J. Comp. Neurol. 180,509-532.
10. Fallon, J. H., Riley, J. N., and Moore, R. Y. (1978b). Substantia nigra dopamine neurons: separate populations project to neostriatum and allocortex. Neurosci. Lett. 7, 157-162.
11. Fallon, J. H., and Moore, R. Y. (1978a). Catecholamine innervation of the basal forebrain III Olfactory bulb, anterior olfactory nuclei, olfactory tubercle and piriform cortex. J. Comp. Neurol. 180, 533-544.
12. Fallon, J. H., and Moore, R. Y. (1978b). Catecholamine innervation of the basal forebrain IV: topography of the dopamine projection to the basal forebrain and neostriatum. J. Comp. Neurol. 180, 545-580.
13. Faul, F., Erdfelder, E., Lang, A. G., and Buchner, A. (2007). G* power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 39, 175-191.
14. Gao, X. M., Hashimoto, T., and Tamminga, C. A. (1998). Phencyclidine (PCP) and dizocilpine (MK801) exert time-dependent effects on the expression of immediate early genes in rat brain. Synapse 29, 14-28.
15. Gaspar, P., Stepniewska, I., and Kaas, J. H. (1992). Topography and col-lateralization of the dopaminergic projections to motor and lateral prefrontal cortex in owl monkeys. J. Comp. Neurol. 325,1-21.
16. Haber, S. N., and Fudge, J. L. (1997). The primate substantia nigra and VTA: integrative circuitry and function. Crit. Rev. Neurobiol. 11, 323-342.
17. Haber, S. N., and Gdowski, M. J. (2004). "The basal ganglia," in The Human Nervous System, eds G. Paxinos and J. K. Mai (London: Elsevier Academic Press), 676-738.
18. Halliday, G. (2004). "Substantia nigra and locus coeruleus," in The Human Nervous System, eds G. Paxinos and J. K. Mai (London: Elsevier Academic Press), 449-463.
19. Haycock, J. W. (1990). Phosphorylation of tyrosine hydroxylase in situ at ser-ine 8, 19, 31, and 40. J. Biol. Chem. 265, 11682-11691.
20. Hoogendoorn, M. L. C., Bakker, S. C., Schnack, H. G., Selten, J. P. C., Otten, H. G., Verduijn, W., van der Heijden, E M., Pearson, P. L., Khan, R. S., and Sinke, R. J. (2005). No association between 12 dopaminergic genes and schizophrenia in a large Dutch sample. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134B, 6-9.
21. Ichinose, H., Ohye, T., Fujita, K., Pantucek, F., Lange, K., Riederer, P., and Nagatsu, T. (1994). Quantification of mRNA of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in the substan-tia nigra in Parkinson's disease and schizophrenia. J. Neural Transm. 8, 149-158.
22. Ishiguro, H., Arinami, T., Saito, T., Akazawa, S.,Enomoto,M., Mitushio, H., Fujishiro, H., Tada, K., Akimoto, Y, Mifune, H., Shiozuka, S., Hamaguchi, H., Toru, M., and Shibuya, H. (1998). Systematic search for variations in the tyrosine hydroxylase gene and their associations with schizophrenia, affective disorders, and alcoholism. Am. J. Med. Genet. 81,388-396.
23. Jacewicz, R., Galecki, P., Florkowski, A., and Berent, J. (2008). Association of the tyrosine hydroxylase gene polymorphism with schizophrenia in the population of central Poland. Psychiatr. Pol. 42, 583-593.
24. Joel, D., and Weiner, I. (2000). The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 96, 451-474.
25. Jonsson, E., Brene, S., Geijer, T., Terenius, L., Tylec, A., Persson, M. L., and Sedvall, G. (1996). A search for association between schizophrenia and dopamine-related alleles. Eur. Arch. Psychiatr. Clin. Neurosci. 246, 297-304.
26. Jonsson, E. G., Geijer, T., Gyllander, A., Terenius, L., and Sedvall, G. C. (1998). Failure to replicate an association between a rare allele of a tyrosine hydroxylase gene microsatellite and schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 248, 61-63.
27. Kapur, S., Vanderspek, S. C., Brownlee, B. A., and Nobrega, J. N. (2003). Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy. J. Pharmacol. Exp. Ther. 305, 625-631.
28. Kunugi, H., Kawada, Y., Hattori, M., Ueki, A., Otsuka, M., and Nanko, S. (1998). Association study of structural mutations of the tyrosine hydroxylase gene with schizophrenia and Parkinson's disease. Am. J. Med. Genet. 81, 131-133.
29. Kurumaji, A., Kuroda, T., Yamada, K., Yoshikawa, T., and Toru, M. (2001). An association of the polymorphic repeat of tetranucleotide (TCAT) in the first intron of the human tyrosine hydroxylase gene with schizophrenia in a Japanese sample. J. Neural Transm. 108, 489-495.
30. Lenartowski, R., and Goc, A. (2011). Epigenetic, transcriptional and posttranscriptional regulation of the tyrosine hydroxylase gene. Int. J. Dev. Neurosci. 29, 873-883.
31. Levinson, A. J., Garside, S., Rosebush, P. I., and Mazurek, M. E (1998). Haloperidol induces persistent down-regulation of tyrosine hydroxylase immunore-activity in substantia nigra but no ventral tegmental area in the rat. Neuroscience 84, 201-211.
32. Lewis, D. A., and Gonzalez-Burgos, G. (2006). Pathophysiologically based treatment interventions in schizophrenia. Nat. Med. 12, 1016-1022.
33. Marchese, G., Casu, M. A., Bartholini, E, Ruiu, S., Saba, P., Gessa, G. L., and Pani, L. (2002). Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to "early onset" vacuous chewing. Eur. J. Neurosci. 15, 1187-1196.
34. Mazurek, M. F., Savedia, S. M., Bobba, R. S., Garside, S., and Rosebush, P. I. (1998). Persistent loss of tyrosine hydroxylase immunoreactivity in the substantia nigra after neuroleptic withdrawal. J. Neurol. Neurosurg. Psychiatr. 64, 799-801.
35. McRitchie, D. A., Halliday, G. M., and Cartwright, H. (1995). Quantitative analysis of the variability of substantia nigra pigmented cell clusters in the human. Neuroscience 68, 539-551.
36. Meloni, R., Laurent, C., Campion, D., Hadjali, B. B., Thibaut, F., Dollfus, S., Petit, M., Samolyk, D., Martinez, M., Poirier, M. F., and Mallet, J. (1995). A rare allele of a microsatellite located in the tyrosine hydroxylase gene found in schizophrenic patients. C. R. Acad. Sci. III Sci. Vie 318,803-809.
37. Mueller, H. T., Haroutunian, V., Davis, K. L., and Meador-Woodruff, J. H. (2004). Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia. Brain Res. Mol. Brain Res. 121, 60-69.
38. Nakashima, A., Hayashi, N., Kaneko, Y. S., Mori, K., Sabban, E. L., Nagatsu, T., and Ota, A. (2009). Role of N-terminus of tyrosine hydroxylase in the biosynthesis of cate-cholamines. J. Neural Transm. 116, 1355-1362.
39. Ota, M., Nakashima, A., Ikemoto, K., Nojima, S., Tanaka, M., Okuda, M., Koga, H., Mori, K., Kaneko, Y. S., Fujiwara, K., Yamamoto, H., Nagatsu, T., and Ota, A. (2001). Exon 3 of tyrosine hydroxylase gene: lack of association with Japanese schizophrenic patients. Mol. Psychiatry 6, 315-319.
40. Pae, C. U., Kim, J. J., Serretti, A., Lee, C. U., Lee, S. J., Lee, C., and Paik, I. H. (2003). VNTR polymorphism of tyrosine hydroxylase gene and schizophrenia in the Korean population. Neuropsychobiology 47, 131-136.
41. Paxinos, G., and Huang, X. E (1995). Atlas of the Human Brainstem. San Diego: Academic Press. Perez-Costas, E., Guidetti, P., Melendez-Ferro, M., Kelley, J. J., and Roberts, R. C. (2008). Neuroleptics and animal models: feasibility of oral treatment monitored by plasma levels and receptor occupancy assays. J. Neural Transm. 115, 745-753.
42. Perez-Costas, E., Melendez-Ferro, M., and Roberts, R. C. (2010). Basal ganglia pathology in schizophrenia: dopamine connections and anomalies. J. Neurochem. 113, 287-302.
43. Porrino, L. J., and Goldman-Rakic, P. S. (1982). Brainstem innerva-tion of prefrontal and anterior cin-gulate cortex in the rhesus monkey revealed by retrograde transport of HRP. J. Comp. Neurol. 205, 63-76.
44. Roberts, R. C., Roche, J. K., Conley, R. R., and Lahti, A. C. (2009). Dopaminergic synapses in the caudate of subjects with schizophrenia: relationship to treatment response. Synapse 63,520-530.
45. Spitzer, R. L., Williams, J. B., Gibbon, M., and First, M. B. (1992). The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch. Gen. Psychiatry 49, 624-629.
46. Stan, A. D., Ghose, S., Gao, X. M., Roberts, R. C., Lewis-Amezcua, K., Hatanpaa, K. J., and Tamminga, C. A. (2006). Human postmortem tissue: what quality markers matter? Brain Res. 1123,1-11.
47. Talkowski, M. E., Kirov, G., Bamne, M., Georgieva, L., Torres, G., Mansour, H., Chowdari, K. W., Milanova, V., Wood, J., McClain, L., Prasad, K., Shirts, B., Zhang, J., O'Donovan, M. C., Owen, M. J., Devlin, B., and Nimgaonkar, V. L. (2008). A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Hum. Mol. Genet. 17, 747-758.
48. Tank, A. W., Xu, L., Chen, X., Radcliffe, P., and Sterling, C. R. (2008). Post-transcriptional regulation of tyrosine hydroxylase expression in adrenal medulla and brain. Ann. N Y. Acad. Sci. 1148, 238-248.
49. Tejedor-Real, P., Biguet, N. F., Dumas, S., and Mallet, J. (2003). Tyrosine hydroxylase mRNA and protein are down-regulated by chronic cloza-pine in both the mesocorticolim-bic and the nigrostriatal systems. J. Neurosci. Res. 72, 105-115.
50. Thibaut, F., Ribeyre, J. M., Dourmap, N., Meloni, R., Laurent, C., Campion, D., Menard, F. J., Dollfus, S., Mallet, J., and Petit, M. (1997). Association of DNA polymorphism in the first intron of the tyrosine hydroxylase gene with disturbances of the catecholaminergic system in schizophrenia. Schizophr. Res. 23, 259-264.
51. Toru, M., Watanabe, S., Shibuya, H., Nishikawa, T., Noda, K., Mitsushio, H., Ichikawa, H., Kurumaji, A., Takashima, M., Mataga, N., and Ogawa, A. (1988). Neurotransmit-ters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients. Acta Psychiatr. Scand. 78,121-137.
52. Tost, H., Hakimi, S., and Meyer-Lindenberg, A. (2010). "Dopamine dysfunction is schizophrenia: from genetic susceptibility to cognitive impairment," in Dopamine Handbook, eds L. L. Iversen, S. D. Iversen, S. B. Dunnett, and A. Bjorklund (Oxford: Oxford University Press), 558-571.
53. Wei, J., Ramchand, C. N., and Hemmings, G. P. (1995). Association of polymorphic VNTR region in the first intron of the human TH gene with disturbances of the cat-echolamine pathway in schizophrenia. Psychiatr. Genet. 5, 83-88.
54. Wong, D. L., and Tank, A. W. (2007). Stress-induced catecholaminergic function: transcriptional and post-transcriptional control. Stress 10, 121-130.
55. Zhang, Y., Xu, H., He, J., Yang, D., Jiang, W., Li, X., and Li, X. M. (2007). Quetiapine reverses altered locomotor activity and tyrosine hydroxylase immunoreactivity in ra caudate putamen following long-term haloperidol treatment. Neu rosci. Lett. 420, 66-71.